Literature DB >> 19888378

A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: bolus dosing.

Allen B King1, Dana U Armstrong.   

Abstract

BACKGROUND: Current bolus insulin dosing recommendations are based on retrospective studies of patients with Type 1 diabetes in whom the glucose control was not intensely established. Using continuous glucose monitoring (CGM), we prospectively studied these recommendations in patients treated with continuous subcutaneous insulin infusion.
METHODS: Thirty subjects were studied over a mean of two weeks of continuous glucose monitoring with near daily insulin adjustments. First a basal glucose goal was achieved of <5% of values <70 mg/dL and <20%>, 170 mg/dL. Then bolus dosing factors; Insulin to Carbohydrate Ratio (g of meal carbohydrates/unit of insulin, ICR) and Correction Factor (mg/dL fall in blood glucose/unit of insulin, CF); were established for each meal time to a goal of +/- 20% of premeal glucose (ICR) or 80-120 mg/dL (CF) by the fourth post bolus hour.
RESULTS: All treatment goals were achieved in each subject. Modification of formulas from ICR = 450/Total Daily Dose (TDD) to ICR = (217/TDD) + 3 and from CF = 1700/TDD to CF = (1076/TDD) + 12 more closely matched observed results than published formulas. There was no significant difference in each factor with time of day. There was a highly significant relationship between ICR and CF, ICR*4.44 = CF (r = 0.9, p < 0.0005), total basal dose (TBD) and TDD.
CONCLUSIONS: Current formulas need to be modified to provide higher insulin bolus doses. The interrelationships between ICR, CF, TBD and TDD suggest that any change in one may require a change in the others.

Entities:  

Keywords:  bolus; diabetes; glucose; insulin; pump

Year:  2007        PMID: 19888378      PMCID: PMC2769601          DOI: 10.1177/193229680700100107

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  7 in total

1.  Efficacy and reliability of the continuous glucose monitoring system.

Authors:  T M Gross; J J Mastrototaro
Journal:  Diabetes Technol Ther       Date:  2000       Impact factor: 6.118

2.  Daily glucose trend analyses and treatment adjustments using the continuous glucose monitoring system (CGMS, Medtronic MiniMed): "tweaking".

Authors:  Allen B King; Dana U Armstrong
Journal:  Diabetes Technol Ther       Date:  2004-04       Impact factor: 6.118

3.  The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity.

Authors:  G Perriello; P De Feo; E Torlone; C Fanelli; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

4.  A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects.

Authors:  F R Kaufman; L C Gibson; M Halvorson; S Carpenter; L K Fisher; P Pitukcheewanont
Journal:  Diabetes Care       Date:  2001-12       Impact factor: 19.112

5.  Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes.

Authors:  E Boland; T Monsod; M Delucia; C A Brandt; S Fernando; W V Tamborlane
Journal:  Diabetes Care       Date:  2001-11       Impact factor: 19.112

6.  Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study.

Authors:  Johnny Ludvigsson; Ragnar Hanas
Journal:  Pediatrics       Date:  2003-05       Impact factor: 7.124

7.  Prandial insulin requirements in insulin-dependent diabetics: effects of size, time of day, and sequence of meals.

Authors:  F J Service; R A Rizza; L D Hall; R E Westland; P C O'Brien; A H Clemens; M W Haymond; J E Gerich
Journal:  J Clin Endocrinol Metab       Date:  1983-11       Impact factor: 5.958

  7 in total
  11 in total

1.  Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levels.

Authors:  John Walsh; Ruth Roberts; Timothy Bailey
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

Review 2.  Continuous glucose monitoring-guided insulin dosing in pump-treated patients with type 1 diabetes: a clinical guide.

Authors:  Allen B King
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

3.  CGM Retrospective Data Analysis.

Authors:  Gary Scheiner
Journal:  Diabetes Technol Ther       Date:  2016-02       Impact factor: 6.118

4.  Bolus calculator settings in well-controlled type 1 diabetes patients (glycated hemoglobin < 7%) treated with insulin pumps.

Authors:  Bartłomiej Matejko; Małgorzata Grzanka; Beata Kieć-Wilk; Maciej T Małecki; Tomasz Klupa
Journal:  J Diabetes Sci Technol       Date:  2013-05-01

5.  Letter to the editor. A study that glucose control can be achieved in 31 type 1 patients who follow a controlled diet and use an insulin pump that is programmed.

Authors:  John Walsh; Ruth Roberts
Journal:  J Diabetes Sci Technol       Date:  2007-07

Review 6.  Management of Type 1 Diabetes in the Hospital Setting.

Authors:  Carlos E Mendez; Guillermo E Umpierrez
Journal:  Curr Diab Rep       Date:  2017-09-14       Impact factor: 4.810

Review 7.  Reassessment of insulin dosing guidelines in continuous subcutaneous insulin infusion treated type 1 diabetes.

Authors:  Allen Bennett King
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

8.  Insulin Sensitivity Index-Based Optimization of Insulin to Carbohydrate Ratio: In Silico Study Shows Efficacious Protection Against Hypoglycemic Events Caused by Suboptimal Therapy.

Authors:  Michele Schiavon; Chiara Dalla Man; Claudio Cobelli
Journal:  Diabetes Technol Ther       Date:  2018-02       Impact factor: 6.118

9.  Carbohydrate-to-Insulin Ratio in a Mediterranean Population of Type 1 Diabetic Patients on Continuous Subcutaneous Insulin Infusion Therapy.

Authors:  Valeria Alcántara-Aragón; Cintia Gonzalez; Rosa Corcoy; Justa Ubeda; Ana Chico
Journal:  J Diabetes Sci Technol       Date:  2014-12-17

Review 10.  A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes.

Authors:  Allen B King; Akio Kuroda; Munehide Matsuhisa; Todd Hobbs
Journal:  Curr Diab Rep       Date:  2016-09       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.